Lily Wang, Lanyu Zhang, Juan Young, Lissette Gomez, Tiago C Silva, Michael A. Schmidt, Zixi Cai, Brian W. Kunkle, Eden R Martin
Abstract
Sex is an important factor that contributes to both clinical and biological heterogeneity in Alzheimer's disease (AD), but the regulatory mechanisms underlying sex differences in AD are still not well understood. DNA methylation is an epigenetic modification that regulates gene transcription and is known to be involved in AD.
We performed the first large-scale sex-specific meta-analysis of DNA methylation changes in AD by re-analyzing four recent epigenome-wide association studies (totaling more than 1000 postmortem prefrontal cortex brain samples) using a uniform analytical pipeline. For each cohort we employed two complementary analytical strategies: a sex-stratified analysis that examined methylation-Braak stage associations in male and female samples separately, and a sex-by-Braak stage interaction analysis that compared the magnitude of these associations between different sexes.
Our analysis uncovered 14 novel CpGs, mapped to genes such as TMEM39A and TNXB, that are associated with AD in a sex-specific manner. TMEM39A is known to be involved in inflammation, dysregulated type I interferon responses, and other immune processes. TNXB encodes tenascin proteins, which are extracellular matrix glycoproteins demonstrated to modulate synaptic plasticity in the brain. Moreover, for many previously implicated AD genes, such as MBP and AZU1, our analysis provided the new insight that they were predominately driven by effects in only one sex. Pathway analysis also highlighted divergent biological processes such as integrin activation in females and complement activation in males.
Our study implicates multiple new loci and biological processes that affected AD in a sex-specific manner, which may help improve understanding of the impact of sex on the epigenetic architecture underlying AD pathology.
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 February 2022.
All research outputs
#15,512,170
of 23,053,169 outputs
Outputs from Alzheimer's & Dementia: the Journal of the Alzheimer's Association
#2,504
of 3,446 outputs
Outputs of similar age
#281,772
of 504,266 outputs
Outputs of similar age from Alzheimer's & Dementia: the Journal of the Alzheimer's Association
#319
of 452 outputs
Altmetric has tracked 23,053,169 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 3,446 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 29.5. This one is in the 20th percentile – i.e., 20% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 504,266 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 452 others from the same source and published within six weeks on either side of this one. This one is in the 21st percentile – i.e., 21% of its contemporaries scored the same or lower than it.
